Numerous studies had shown that FOXD1 was known to promote the malignant processes of various types of cancers, such as pancreatic cancer, gastric cancer, and lung cancer (Cai et al., 2022; Wu et al., 2021; Li et al., 2019). The gene discussed is FOXD1; the disease is familial pancreatic carcinoma.